• Join
  • Login
  • Contact

Search abstracts / presentations

Lamivudine increases hyperbilirubinemic risk in patients with severe hepatitis

  • In: Poster presentation
  • At: Seoul (South Korea) (2017)
  • Type: Poster
  • Poster code: POS-HPS-070
  • By: KIM, Sang Geon (Seoul National University, Seoul, Korea, Republic Of)
  • Co-author(s): Sang Geon Kim:
    Young Hee Choi: College of Pharmacy, Dongguk University, Korea, Republic Of
  • Abstract:


    Lamivudine is effective against hepatitis B virus infection recovering alanine aminotransferase (ALT) to normal ranges through virus eradication. Also, total bilirubin (TB) represents an improvement of liver function from virus infection. Despite its effectiveness, a few case reports raised the possibility that lamivudine causes liver..

  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 28 September 2023

FIP Congresses